Neurotransmitter antagonism in management of irritable bowel syndrome

Lancet. 2000 Mar 25;355(9209):1030-1. doi: 10.1016/S0140-6736(00)02028-6.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Carbolines / therapeutic use*
  • Colonic Diseases, Functional / drug therapy*
  • Colonic Diseases, Functional / physiopathology
  • Humans
  • Serotonin / physiology
  • Serotonin Antagonists / therapeutic use*

Substances

  • Carbolines
  • Serotonin Antagonists
  • alosetron
  • Serotonin